CVR: 33373236
DKK -98,936
Gross profit
Net result: DKK -95,786
Melius Pharma AB
CVR · view ownership and management
Director role ended: John Bondo Hansen
CVR · 28/11/2022
View the full event history
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.
Selskabets formål er at drive virksomhed med udvikling, produktion, markedsføring og salg af lægemidler og dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -99 t. | -96 t. | 66 t. | 0 | 0 | |
| 202401/01/2024 – 31/12/2024 | -92 t. | -100 t. | 69 t. | 25 t. | - | |
| 202301/01/2023 – 31/12/2023 | -506 t. | -511 t. | 39 t. | -102 t. | - | |
| 202201/01/2022 – 31/12/2022 | 1.3 mio. | 1.2 mio. | 1.2 mio. | 409 t. | - | |
| 202101/01/2021 – 31/12/2021 | -246 t. | -308 t. | 53 t. | -1.7 mio. | - | |
| 202001/01/2020 – 31/12/2020 | -555 t. | -604 t. | 250 t. | -1.4 mio. | - | |
| 201901/01/2019 – 31/12/2019 | -165 t. | -198 t. | 226 t. | -793 t. | - | |
| 201801/01/2018 – 31/12/2018 | -388 t. | -398 t. | 97 t. | -595 t. | - | |
| 201701/01/2017 – 31/12/2017 | -305 t. | -286 t. | 139 t. | -197 t. | - | |
| 201601/01/2016 – 31/12/2016 | -684 t. | -531 t. | 273 t. | 90 t. | - | |
| 201501/01/2015 – 31/12/2015 | -89 t. | -74 t. | 640 t. | 620 t. | - | |
| 201401/01/2014 – 31/12/2014 | -93 t. | -81 t. | 209 t. | 94 t. | - | |
| 201301/01/2013 – 31/12/2013 | -228 t. | -274 t. | 302 t. | 276 t. | - | |
| 201201/01/2012 – 31/12/2012 | -266 t. | -244 t. | 230 t. | 200 t. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCONRIG PHARMA ApS was founded on 20 December 2010.
CONRIG PHARMA ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
CONRIG PHARMA ApS had 0 employees in 2011 according to the Danish CVR register.
CONRIG PHARMA ApS is owned by Melius Pharma AB.
In 2025, CONRIG PHARMA ApS reported a gross profit of DKK -98,936.
The management of CONRIG PHARMA ApS consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus.
Claim this page to add your logo and social links. Free to get started.
CONRIG PHARMA ApS has published its annual report for 2025. Gross profit came to DKK -98,936, and the net result was DKK -95,786.
CONRIG PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -92,016, and the net result was DKK -100,217.
CONRIG PHARMA ApS has published its annual report for 2023. Gross profit came to DKK -506,147, and the net result was DKK -510,872.
CONRIG PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 1,265,932, and the net result was DKK 1,244,502.
As of November 28, 2022, Snickar Karl Johan Tobieson has joined the board of directors of CONRIG PHARMA ApS.
As of November 28, 2022, Lars Christer Fredrik Fåhraeus has joined the board of directors of CONRIG PHARMA ApS.
As of November 28, 2022, John Bondo Hansen has left the board of directors of CONRIG PHARMA ApS.
As of November 28, 2022, Mikael Søndergaard Thomsen has left the board of directors of CONRIG PHARMA ApS.
As of November 28, 2022, Snickar Karl Johan Tobieson is registered as director of CONRIG PHARMA ApS.
As of November 28, 2022, Lars Christer Fredrik Fåhraeus is registered as director of CONRIG PHARMA ApS.
As of November 28, 2022, John Bondo Hansen has stepped down as director of CONRIG PHARMA ApS.
As of November 28, 2022, Mikael Søndergaard Thomsen has stepped down as director of CONRIG PHARMA ApS.
CONRIG PHARMA ApS has published its annual report for 2021. Gross profit came to DKK -246,326, and the net result was DKK -308,167.
As of February 8, 2022, is registered as an owner of CONRIG PHARMA ApS with an ownership share of 100%.
CONRIG PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -555,136, and the net result was DKK -603,545.
CONRIG PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -165,433, and the net result was DKK -198,499.
CONRIG PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -387,513, and the net result was DKK -398,031.
CONRIG PHARMA ApS has published its annual report for 2017. Gross profit came to DKK -304,565, and the net result was DKK -286,337.
CONRIG PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -683,941, and the net result was DKK -530,670.
CONRIG PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -88,540, and the net result was DKK -73,599.
As of November 24, 2015, John Bondo Hansen has joined the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Niels Skjærbæk has joined the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Mikael Søndergaard Thomsen has joined the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Frank Knudsen has left the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Else Sissel Vorstrup has left the board of directors of CONRIG PHARMA ApS.
As of November 23, 2015, John Bondo Hansen has left the board of directors of CONRIG PHARMA ApS.
CONRIG PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -92,788, and the net result was DKK -81,341.
CONRIG PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -227,519, and the net result was DKK -274,036.
CONRIG PHARMA ApS has published its annual report for 2012. Gross profit came to DKK -265,781, and the net result was DKK -243,991.
As of October 2, 2012, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of CONRIG PHARMA ApS.
As of October 2, 2012, EY Godkendt Revisionspartnerselskab has stepped down as auditor of CONRIG PHARMA ApS.
As of June 1, 2011, John Bondo Hansen has joined the board of directors of CONRIG PHARMA ApS.
As of June 1, 2011, Frank Knudsen has joined the board of directors of CONRIG PHARMA ApS.
As of June 1, 2011, Else Sissel Vorstrup has joined the board of directors of CONRIG PHARMA ApS.
As of December 20, 2010, EY Godkendt Revisionspartnerselskab has been appointed auditor of CONRIG PHARMA ApS.
As of December 20, 2010, John Bondo Hansen is registered as director of CONRIG PHARMA ApS.
As of December 20, 2010, Mikael Søndergaard Thomsen is registered as director of CONRIG PHARMA ApS.
CONRIG PHARMA ApS was founded on December 20, 2010.
Companies in the same industry and area
CVR 34623562
CVR 38445928
CVR 29526346
CVR 37728403
CVR 40279865
